About EPDA Plus

“The EPDA Plus magazine we received was absolutely magic. I have never seen anything like it, in particular the article UNMASKING THE TRUTH. This was just so powerful and accurate it amazed me. I have never read such an accurate description of a PWP.

Your Magazine is always so helpful as unfortunately we do not have anything that deals with issues like you do. I look forward to your next one. You have brought a ray of sunshine into our lives with all your wonderful information.”

Judith Ashford OAM
President Parkinson's Society of the Gold Coast, Queensland, Western Australia

EPDA Plus is an exciting publication targeting international healthcare professionals. By broadening the magazine's appeal to a wider healthcare audience of consultant neurologists, general physicians, nurses, and allied healthcare professionals EPDA Plus will enable supporters/advertisers to reach a significantly wider audience. Also, by distributing the publication through standard as well as electronic media, the potential audience reach is over 10,000 individuals.

EPDA Plus is published 3 times a year (Spring, Summer and Winter) and reports predominantly on issues of international interest. It will inform policy-makers and engage those working in the field of Parkinson’s disease and will include:

Headline news and views from around the globe
Focus articles on topical issues in the world of PD
Interviews with leading international personalities
Features focussing on international organisations
EPDA news and updates
Profiles to Patient Organisations throughout Europe
Research News reporting on new trials, recruitment and patient surveys
Interviews with leading international researchers
Research Features on topical research in the field of PD
Political news and developments including policy briefings, campaigning, lobbying and media reports
Assistive Technology reviews of technological solutions for people with physical, cognitive and speech difficulties
Calendar of conferences
Publications and resources including reviews

EPDA PLUS Global Distribution

[Click here for further breakdown]

Distribution of EPDA Plus

Circulation

EPDA Plus is circulated to over 2,000 international healthcare professionals including prescribers
EPDA Plus is distributed at annual international congresses and other PD events throughout the year
EPDA Plus is distributed by post and email as well as being available on-line

EPDA Plus will be published and distributed in Spring, Summer and Winter

All enquires regarding advertising or submission should be directed to epdaplus@epda.eu.com or Tel: +44 (0) 1732 457 683

Background

The EPDA, formed in June 1992 in Munich with a membership of 9 European Parkinson's Patient organisations now has 39 members.¹ It also has 7 Associate members including the Movement Disorder Society, the European Federation of Neurological Associations, the Association of Physical Therapists for Europe and the Tremor Foundation.

It is a non-political, non-religious, and non-profit making organisation concerned with the health and welfare of people living with Parkinson's disease and their families, across Europe and internationally. The organisation continually strives to be at the forefront of development and innovation, and to this end, the EPDA board have taken a strategic decision to develop the content and style of the EPDA Plus magazine to reflect the interests of its extended membership.

from Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Faeroe Islands, Finland, France, Georgia, Hungary, Iceland, Ireland, Israel, Italy, Lithuania, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovenia, Sweden, Switzerland, Turkey, Ukraine and UK.

Partnership for Progress - ‘Promoting a constructive dialogue between science and society’

The EPDA achieves its success through combining the strengths and experiences of its partners. It has provided an important forum to work in collaboration with European organisations, both patient and neurological, the European Commission, the World Health Organisation, the World Federation of Neurology, and the pharmaceutical industry. This partnership has enabled the development of research projects into quality of life issues, and conferences for multidisciplinary teams and people with Parkinson's of any age.